The Amplius Approach
To Every Project

Our business design approach will guide you through a structured yet flexible innovation journey that will help you find your next great opportunity beyond the resources you presently control, whether you are preparing to establish a new business model, product or service.

Our Services

Amplius Business Design offers comprehensive Business Plans, Business Process Optimization, Due Diligence Reviews, and Medical Expertise in Drug Discovery. Whether you need a full report or specific sections, we tailor our services to your needs and provide the flexibility of a ‘à la carte’ option. What sets us apart is our optional Fractional Chief Business Officer (CBO) service, which ensures ongoing monitoring, adaptation, and implementation of your business strategy.

We’ll work with you through every step—offering expert guidance, tracking milestones, and adjusting strategies in real time to keep you on course for success. Let us help you stay relevant and successfully achieve your business objectives.

The Fractional CBO service offers ongoing leadership and guidance, ensuring your business stays on track as it adapts to market changes. By working closely with your C-suite, stakeholders, and advisors, we ensure that recommendations are implemented effectively and aligned with strategic goals. Our service provides the ongoing support needed to drive success, improve efficiency, and ensure long-term sustainability.

  • Our Business Plan Development & Growth Strategy Report is designed for a diverse range of clients, including biotech startups and early-stage companies, investors (private equity and venture capital), pharmaceutical companies, healthcare providers, non-profit healthcare organizations, and health tech companies. 

    You are a biotech startup seeking funding or market entry, an investor evaluating potential investments, or a healthcare provider aiming to diversify and expand. This service is particularly valuable for clients at key decision-making stages, whether refining their business model, identifying growth opportunities, or attracting investment.

    Key analysis areas include:

    • Strategic Positioning: We assess your mission, vision, and value proposition, ensuring they align with market trends and customer needs to maintain a competitive edge and differentiate your offerings.

    • Business Model: We refine your business model, focusing on scalable revenue streams, cost optimization, and growth potential across product, service, or subscription models.

    • Market Analysis & Competitive Landscape: We analyze market trends, customer needs, and competitor strategies to help your company effectively target the right customer segments and navigate regulatory factors.

    • Market and Financial Viability: We review financial projections, including funding needs, revenue forecasts, and cost structures, ensuring a solid financial foundation to track growth and secure future funding.

    • Growth Pathways & Business Milestones: We identify strategic opportunities for expansion and set clear business milestones (e.g., product launches, regulatory approvals) to ensure alignment with growth objectives.

    • Risk and Compliance: We assess potential market, financial, operational, and regulatory risks and provide strategies for mitigation and compliance with industry standards.

    This comprehensive business plan provides a clear, actionable strategy for scaling your company, attracting investment, and positioning it for future success. Whether you are a startup, investor, healthcare provider, or health tech company, our report will help you secure the necessary funding and support to drive growth and achieve your business goals.

  • Our Business Process Optimization & Financial Benchmarking Report is specifically designed to support a wide range of clients within the life sciences and healthcare sectors, including biotech start-ups and scale-ups, pharmaceutical companies, private equity and venture capital investors, healthcare providers, government health agencies, non-profit healthcare organizations, and academic & research institutions.

    You are a rapidly growing biotech firm, an investor evaluating a portfolio company, or an academic institution seeking process improvements. We provide tailored insights and actionable recommendations to optimize operations, drive innovation, and ensure financial sustainability.

    Key analysis areas include:

    • Business Model Adaptation: Aligning your business model with evolving market trends, research advancements, and customer needs to maintain a competitive edge.

    • Portfolio Optimization: Evaluating your research, products, and services to ensure they align with your long-term goals, optimizing investments and streamlining underperforming areas.

    • Operational Efficiency: Identifying process inefficiencies and recommending improvements to boost productivity, reduce costs, and streamline workflows.

    • Financial Benchmarking: Analyzing your financial performance against industry peers to identify opportunities for cost optimization and increased profitability.

    • Technological Integration: Assessing the effectiveness of your existing technology infrastructure and recommending tools or automation to enhance productivity and innovation.

    • Organizational Readiness for Change: Evaluating the readiness of your teams for change, ensuring employee engagement and successful adoption of improvements.

    • Sustainability & Compliance: Ensuring your operations align with sustainability goals and meet industry regulations, including environmental impact, product quality, and compliance standards.

    No matter where you are in your biotech journey—whether scaling up, optimizing efficiency, or assessing portfolio performance—our report provides clear, actionable insights that help you optimize operations, enhance financial performance, and stay at the forefront of innovation.

  • Our Medical Expertise and Drug Discovery Strategy Report is tailored for clients deeply engaged in the discovery, development, and commercialization of drugs and medical treatments. This service is invaluable to biotech and pharmaceutical companies, contract research organizations (CROs), academic and research institutions, government health agencies, investors (venture capital and private equity), and non-profit health organizations. 

    You are refining a drug discovery pipeline, strategizing for clinical trials, or looking to align your research with unmet medical needs. We offer the expert analysis and strategic insights necessary to advance your projects and enhance clinical relevance.

    Key analysis areas include:

    • Strategic Clinical Relevance: We directly assist in identifying, refining, and addressing unmet medical needs across both existing and new therapeutic areas, ensuring that your drug candidates are aligned with critical patient needs and clinical trends.

    • Expert Team and Collaborations: We evaluate your team’s expertise and collaborations with clinical advisors, ensuring strong support for advancing your drug discovery.

    • Pipeline Evaluation: We assess your drug candidates’ stages, milestones, and timelines to identify areas for improvement and expedite progress.

    • Regulatory and Clinical Pathways: We advise on regulatory strategies and identify opportunities to leverage accelerated approval pathways for faster clinical trial entry.

    • Partnership and Funding Strategies: We explore opportunities for strategic partnerships and funding sources to ensure your pipeline has the necessary resources.

    • IP and Commercialization: We review your IP portfolio and guide you in licensing and commercialization strategies to protect and bring your drug to market.

    • Financial Strategy: We help identify funding sources, including grants and partnerships, to support your drug development efforts.

    This comprehensive analysis ensures that your drug discovery efforts are clinically relevant, strategically positioned, and financially supported. By leveraging our expertise, we guide your pipeline toward successful clinical outcomes, market entry, and long-term success, helping you navigate the complex challenges of drug discovery and development.

  • Our Due Diligence Review Report is essential for clients involved in high-stakes transactions, such as mergers, acquisitions, or strategic partnerships, and is designed for private equity and venture capital investors, biotech and pharmaceutical companies, corporate M&A advisors, healthcare providers and systems, investment banks, and non-profit healthcare organizations. 

    You are an investor evaluating a potential acquisition or a healthcare provider considering a merger. This report offers comprehensive insights to assess the risks, opportunities, and true value of assets, guiding your decisions with thorough, evidence-based analysis.

    Key analysis areas include:

    • Strategic Positioning & Market Viability: We assess your company’s alignment with market trends, growth opportunities, and competitive dynamics to ensure a strong market position.

    • Business Model & Operational Effectiveness: We analyze your business model, supply chain, R&D capabilities, and IP portfolio, identifying scalability and operational strengths or risks.

    • Financial Health & Projections: We review key financials, revenue models, and funding structures, ensuring financial viability. If needed, we perform an asset valuation, assessing the value of physical and intellectual assets, such as patents and proprietary technology.

    • Regulatory Compliance & Risk Mitigation: We examine regulatory compliance, industry standards, and legal risks, offering strategies to mitigate these challenges.

    • Market and Competitive Landscape: We analyze market trends, customer needs, and competitors, providing insights to help differentiate your offerings and secure a competitive edge.

    • Business Milestones & Growth Pathways: We identify key milestones and growth strategies to scale across new markets and opportunities.

    • Management & Team Evaluation: We assess your leadership team and organizational structure, ensuring alignment with strategic goals and identifying talent gaps.

    This report provides critical insights needed to make informed investment or acquisition decisions, giving all parties—investors, companies, and advisors—the confidence to proceed with mergers, acquisitions, and strategic partnerships. Whether or not a valuation is included, our due diligence report ensures that you have the complete picture to evaluate the true value and risks of any potential transaction.

  • Our Fractional Chief Business Officer (CBO) service caters to a wide range of clients in the Life Sciences and Healthcare sectors. Whether you’re a growing biotech startup, an investor, healthcare provider, not-for-profit, or pharmaceutical company, we provide flexible, strategic leadership to monitor business performance, scale operations, and implement key milestones. Our part-time, executive-level expertise ensures that your strategies are executed, progress is tracked, and alignment with business goals is maintained—while collaborating closely with your C-suite, stakeholders, and advisors.

    Key Areas of Focus Include:

    • Strategic Guidance & Leadership: We provide direction and executive leadership, working with your C-suite, stakeholders, and advisors to make critical decisions aligned with long-term goals.

    • Business Plan Adaptation & Evolution: We refine your business model and strategies to stay aligned with market trends and opportunities, ensuring sustainable growth.

    • Milestone Tracking & Reporting: We collaborate to track key milestones, including product launches, regulatory approvals, and hiring, providing structured reports to keep stakeholders informed.

    • Financial Oversight & Funding Strategy: We oversee budgeting, financial forecasting, and funding strategies, ensuring financial health and supporting long-term growth.

    • Risk Management & Compliance: We help mitigate operational, financial, and regulatory risks, ensuring compliance with industry standards and protecting your business.

    • Operational Efficiency & Scalability: We streamline internal processes to improve productivity, reduce costs, and enhance scalability for continued growth.


    The Fractional CBO service offers ongoing leadership and guidance, ensuring your business stays on track as it adapts to market changes. By working closely with your C-suite, stakeholders, and advisors, we ensure that recommendations are implemented effectively and aligned with strategic goals. Our service provides the ongoing support needed to drive success, improve efficiency, and ensure long-term sustainability.

Our Growing Portfolio

View More

What We Do